Global Substance Abuse Treatment Market Growth (Status and Outlook) 2023-2029

Global Substance Abuse Treatment Market Growth (Status and Outlook) 2023-2029

Substance abuse has become a major cause of concern. People are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes and cardiovascular disorders, have increased substantially among consumers, creating a high economic burden on the nation.

LPI (LP Information)' newest research report, the “Substance Abuse Treatment Industry Forecast” looks at past sales and reviews total world Substance Abuse Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Substance Abuse Treatment sales for 2023 through 2029. With Substance Abuse Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Substance Abuse Treatment industry.

This Insight Report provides a comprehensive analysis of the global Substance Abuse Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Substance Abuse Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Substance Abuse Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Substance Abuse Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Substance Abuse Treatment.

The global Substance Abuse Treatment market size is projected to grow from US$ 17450 million in 2022 to US$ 27350 million in 2029; it is expected to grow at a CAGR of 6.6% from 2023 to 2029.

The rise in government initiatives for improved awareness is identified as one of the primary growth factors for this market. Various programs and initiatives have been set up by government agencies and many organisations to increase awareness about the chronic ill-effects of substance abuse. These include initiatives taken up at work places, community programs, and technical assistance programs at local, state, and national levels. The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S Department of Health and Human Services has multiple programs to improve awareness. SAMHSA's Division of Workplace Programs (DWP) supervises programs to eradicate illicit drug use in federal workplaces and helps all workplaces become drug-free. Under this program, DWP regulates various policies for a drug-free workplace.

This report presents a comprehensive overview, market shares, and growth opportunities of Substance Abuse Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Alcohol Abuse Treatment
Nicotine Abuse Treatment
Drug Abuse Treatment

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alkermes
Allergan
GSK
Pfizer
Accord Healthcare
Amphastar Pharmaceuticals
Apotex
BioCorRx
Cipla
Glenmark

Please note: The report will take approximately 2 business days to prepare and deliver.